Introduction: Artificial dermal substitutes aim to restore or reconstruct the dermal layer of skin. Novosorb Biodegradable Temporising Matrix (‘BTM’) has been indicated for the treatment of deep dermal or full thickness wounds, where the entire dermal structure has been lost or damaged. In our experience at the Western Australian Paediatric State Burns Unit, the product has played an important role in the major burns setting; however, there remains a paucity of data with regards to its use in the paediatric population. The aim of this study was to examine the safety and effectiveness of BTM in the paediatric major burns setting. 
 Methods: All paediatric patients whom BTM was applied for an acute burn injury from December 2019 to October 2024 were captured. Medical records, operation reports and medical photography were reviewed; and demographics, burn injury details, percentage of burn treated with BTM, and any peri-operative complications were recorded. 
 Results: A total of 14 patients were identified. Majority were male, with an average age of 7.9 years. Burn sizes ranged from 0.5% to 90% total body surface area (TBSA), with a mean %TBSA of 26.2%. The mean percentage TBSA treated with BTM was 15%, with an average time to delamination of 21.5 days. There were 4 (30.7%) cases of infections requiring antibiotics and 5 (38.5%) patients who required regrafting. There was an overall 93% integration rate. Conclusions: BTM offers a safe and reliable option for rapid wound temporisation in the setting of acute major paediatric burns.